{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:25:17Z","timestamp":1790270717789,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["NRF 2021R1I1A3059241"],"award-info":[{"award-number":["NRF 2021R1I1A3059241"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The progression of Alzheimer\u2019s dementia (AD) can be classified into three stages: cognitive unimpairment (CU), mild cognitive impairment (MCI), and AD. The purpose of this study was to implement a machine learning (ML) framework for AD stage classification using the standard uptake value ratio (SUVR) extracted from <jats:sup>18<\/jats:sup>F-flortaucipir positron emission tomography (PET) images. We demonstrate the utility of tau SUVR for AD stage classification. We used clinical variables (age, sex, education, mini-mental state examination scores) and SUVR extracted from PET images scanned at baseline. Four types of ML frameworks, such as logistic regression, support vector machine (SVM), extreme gradient boosting, and multilayer perceptron (MLP), were used and explained by Shapley Additive Explanations (SHAP) to classify the AD stage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of a total of 199 participants, 74, 69, and 56 patients were in the CU, MCI, and AD groups, respectively; their mean age was 71.5\u00a0years, and 106 (53.3%) were men. In the classification between CU and AD, the effect of clinical and tau SUVR was high in all classification tasks and all models had a mean area under the receiver operating characteristic curve (AUC)\u2009&gt;\u20090.96. In the classification between MCI and AD, the independent effect of tau SUVR in SVM had an AUC of 0.88 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), which was the highest compared to other models. In the classification between MCI and CU, the AUC of each classification model was higher with tau SUVR variables than with clinical variables independently, which yielded an AUC of 0.75(<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in MLP, which was the highest. As an explanation by SHAP for the classification between MCI and CU, and AD and CU, the amygdala and entorhinal cortex greatly affected the classification results. In the classification between MCI and AD, the para-hippocampal and temporal cortex affected model performance. Especially entorhinal cortex and amygdala showed a higher effect on model performance than all clinical variables in the classification between MCI and CU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The independent effect of tau deposition indicates that it is an effective biomarker in classifying CU and MCI into clinical stages using MLP. It is also very effective in classifying AD stages using SVM with clinical information that can be easily obtained at clinical screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12938-023-01107-w","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:01:44Z","timestamp":1682776904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Machine learning application for classification of Alzheimer's disease stages using 18F-flortaucipir positron emission tomography"],"prefix":"10.1186","volume":"22","author":[{"given":"Sang Won","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghyun","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Yum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gihwan","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"1107_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00702-019-01975-4","volume":"126","author":"H Wilson","year":"2019","unstructured":"Wilson H, Pagano G, Politis M. Dementia spectrum disorders: lessons learnt from decades with PET research. J Neural Transm. 2019;126:233\u201351.","journal-title":"J Neural Transm"},{"key":"1107_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"1107_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89:971\u201382.","journal-title":"Neuron"},{"key":"1107_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1107_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"1107_CR6","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1007\/s00415-015-7711-x","volume":"262","author":"L Rocchi","year":"2015","unstructured":"Rocchi L, Niccolini F, Politis M. Recent imaging advances in neurology. J Neurol. 2015;262:2182\u201394.","journal-title":"J Neurol"},{"key":"1107_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","volume":"10","author":"M Politis","year":"2014","unstructured":"Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014;10:708\u201322.","journal-title":"Nat Rev Neurol"},{"key":"1107_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00415-012-6428-3","volume":"259","author":"M Politis","year":"2012","unstructured":"Politis M, Piccini P. Positron emission tomography imaging in neurological disorders. J Neurol. 2012;259:1769\u201380.","journal-title":"J Neurol"},{"key":"1107_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-019-0325-5","volume":"14","author":"F M\u00e1rquez","year":"2019","unstructured":"M\u00e1rquez F, Yassa MA. Neuroimaging biomarkers for Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:21.","journal-title":"Mol Neurodegener"},{"key":"1107_CR10","first-page":"20180511","volume":"474","author":"IA Kuznetsov","year":"2018","unstructured":"Kuznetsov IA, Kuznetsov AV. Simulating the effect of formation of amyloid plaques on aggregation of Tau protein. Proc Math Phys Eng Sci. 2018;474:20180511.","journal-title":"Proc Math Phys Eng Sci"},{"key":"1107_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351\u20137.","journal-title":"Neurobiol Aging"},{"key":"1107_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00693783","volume":"73","author":"C Duyckaerts","year":"1987","unstructured":"Duyckaerts C, Brion JP, Hauw JJ, Flament-Durand J. Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian\u2019s protargol method. Acta Neuropathol. 1987;73:167\u201370.","journal-title":"Acta Neuropathol"},{"key":"1107_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017;15:648\u201357.","journal-title":"Data Brief"},{"key":"1107_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80:247\u201358.","journal-title":"Ann Neurol"},{"key":"1107_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","volume":"73","author":"L Wang","year":"2016","unstructured":"Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, et al. Evaluation of tau imaging in staging Alzheimer disease and revealing interactions Between \u03b2-amyloid and tauopathy. JAMA Neurol. 2016;73:1070\u20137.","journal-title":"JAMA Neurol"},{"key":"1107_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","volume":"14","author":"VL Villemagne","year":"2015","unstructured":"Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. Lancet Neurol. 2015;14:114\u201324.","journal-title":"Lancet Neurol"},{"key":"1107_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jalz.2015.06.006","volume":"11","author":"M Sch\u00f6ll","year":"2015","unstructured":"Sch\u00f6ll M, Schonhaut D, Lockhart S, Vogel JW, Baker S, Schwimmer H, et al. In vivo braak staging using 18F-AV1451 Tau PET imaging. Alzheimers Dement. 2015;11:4.","journal-title":"Alzheimers Dement"},{"key":"1107_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack","year":"2017","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13:205\u201316.","journal-title":"Alzheimers Dement"},{"key":"1107_CR19","first-page":"519","volume":"10","author":"E Pellegrini","year":"2018","unstructured":"Pellegrini E, Ballerini L, del Hernandez MCV, et al. Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: a systematic review. Alzheimers Dement Diagn Assess Dis Monit. 2018;10:519\u201335.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit."},{"key":"1107_CR20","doi-asserted-by":"publisher","first-page":"e0244773","DOI":"10.1371\/journal.pone.0244773","volume":"16","author":"M Velazquez","year":"2021","unstructured":"Velazquez M, Lee Y, Alzheimer\u2019s Disease Neuroimaging Initiative. Random forest model for feature-based Alzheimer\u2019s disease conversion prediction from early mild cognitive impairment subjects. PLoS ONE. 2021;16:e0244773.","journal-title":"PLoS ONE"},{"key":"1107_CR21","first-page":"792","volume":"12261","author":"X Li","year":"2020","unstructured":"Li X, Zhou Y, Dvornek NC, Gu Y, Ventola P, Duncan JS. Efficient Shapley explanation for features importance estimation Under uncertainty. Med Image Comput Comput Assist Interv. 2020;12261:792\u2013801.","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"1107_CR22","doi-asserted-by":"publisher","first-page":"106584","DOI":"10.1016\/j.cmpb.2021.106584","volume":"214","author":"Y Nohara","year":"2022","unstructured":"Nohara Y, Matsumoto K, Soejima H, Nakashima N. Explanation of machine learning models using Shapley additive explanation and application for real data in hospital. Comput Methods Programs Biomed. 2022;214:106584.","journal-title":"Comput Methods Programs Biomed"},{"key":"1107_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/alz.12422","volume":"18","author":"DP Veitch","year":"2022","unstructured":"Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green RC, et al. Using the Alzheimer\u2019s disease neuroimaging initiative to improve early detection, diagnosis, and treatment of Alzheimer\u2019s disease. Alzheimers Dement. 2022;18:824\u201357.","journal-title":"Alzheimers Dement"},{"key":"1107_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2017.00311","volume":"9","author":"W Hu","year":"2017","unstructured":"Hu W, Wu F, Zhang Y, Gong CX, Iqbal K, Liu F. Expression of tau pathology-related proteins in different brain regions: a molecular basis of tau pathogenesis. Front Aging Neurosci. 2017;9:311.","journal-title":"Front Aging Neurosci"},{"key":"1107_CR25","doi-asserted-by":"publisher","first-page":"118553","DOI":"10.1016\/j.neuroimage.2021.118553","volume":"243","author":"CB Young","year":"2021","unstructured":"Young CB, Landau SM, Harrison TM, Poston KL, Mormino EC, ADNI. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data. Neuroimage. 2021;243:118553.","journal-title":"Neuroimage"},{"issue":"7","key":"1107_CR26","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00259-021-05191-9","volume":"48","author":"V Dor\u00e9","year":"2021","unstructured":"Dor\u00e9 V, Krishnadas N, Bourgeat P, Huang K, Li S, Burnham S, et al. Relationship between amyloid and tau levels and its impact on tau spreading. Eur J Nucl Med Mol Imaging. 2021;48(7):2225\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1107_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12530-022-09467-9","author":"N Goenka","year":"2022","unstructured":"Goenka N, Tiwari S. Multi-class classification of Alzheimer\u2019s disease through distinct neuroimaging computational approaches using Florbetapir PET scans. Evol Syst. 2022. https:\/\/doi.org\/10.1007\/s12530-022-09467-9.","journal-title":"Evol Syst"},{"key":"1107_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100710","volume":"25","author":"K Shirbandi","year":"2021","unstructured":"Shirbandi K, Khalafi M, Mirza-Aghazadeh-Attari M, Tahmasbi M, Kiani Shahvandi H, Javanmardi P, et al. Accuracy of deep learning model-assisted amyloid positron emission tomography scan in predicting Alzheimer\u2019s disease: a systematic review and meta-analysis. Inform Med Unlocked. 2021;25: 100710.","journal-title":"Inform Med Unlocked"},{"key":"1107_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease. Neuroimage. 2017;157:448\u201363.","journal-title":"Neuroimage"},{"key":"1107_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2967\/jnumed.116.175273","volume":"58","author":"SL Baker","year":"2017","unstructured":"Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, et al. Reference tissue-based kinetic evaluation of 18F-AV-1451 for tau imaging. J Nucl Med. 2017;58:332\u20138.","journal-title":"J Nucl Med"},{"key":"1107_CR31","doi-asserted-by":"publisher","first-page":"14950","DOI":"10.1038\/s41598-020-70978-z","volume":"10","author":"SH Cho","year":"2020","unstructured":"Cho SH, Choe YS, Park S, Kim YJ, Kim HJ, Jang H, et al. Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid. Sci Rep. 2020;10:14950.","journal-title":"Sci Rep"},{"key":"1107_CR32","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1007\/s00259-018-4040-1","volume":"45","author":"J Chen","year":"2018","unstructured":"Chen J, Li Y, Pirraglia E, Okamura N, Rusinek H, de Leon MJ, Alzheimer\u2019s Disease Neuroimaging Initiative. Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer\u2019s disease with standardized uptake value peak-alignment (SUVP) normalization. Eur J Nucl Med Mol Imaging. 2018;45:1596\u2013604.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1107_CR33","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","volume":"48","author":"A Leuzy","year":"2021","unstructured":"Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N, et al. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging. 2021;48:2295\u2013305.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1107_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement. 2015;11:964\u201374.","journal-title":"Alzheimers Dement"},{"key":"1107_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.06.4839","author":"V Kotari","year":"2019","unstructured":"Kotari V, Navitsky M, Southekal S, Kennedy I, Harris T, Lu M, et al. Early tau detection and implications for disease progression. Alzheimers Dement. 2019. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.4839.","journal-title":"Alzheimers Dement"},{"key":"1107_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2967\/jnumed.111.090340","volume":"53","author":"AD Joshi","year":"2021","unstructured":"Joshi AD, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer\u2019s disease and cognitively normal subjects. J Nucl Med. 2021;53:378\u201384.","journal-title":"J Nucl Med"},{"key":"1107_CR37","doi-asserted-by":"publisher","first-page":"19576","DOI":"10.1038\/s41598-020-76102-5","volume":"10","author":"SH Cho","year":"2020","unstructured":"Cho SH, et al. Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments. Sci Rep. 2020;10:19576.","journal-title":"Sci Rep"},{"key":"1107_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11634-014-0194-2","author":"J Feng","year":"2014","unstructured":"Feng J, Xu H, Mannor S, Yan S. Robust logistic regression and classification. Adv Neural Inf Proc Sys. 2014. https:\/\/doi.org\/10.1007\/s11634-014-0194-2.","journal-title":"Adv Neural Inf Proc Sys"},{"key":"1107_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00994018","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20:273\u201397.","journal-title":"Mach Learn"},{"key":"1107_CR40","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016; pp. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"1107_CR41","volume-title":"The elements of statistical learning","author":"T Hastie","year":"2022","unstructured":"Hastie T. The elements of statistical learning. 2nd ed. Cham: Springer; 2022.","edition":"2"},{"key":"1107_CR42","doi-asserted-by":"publisher","unstructured":"Banerjee K, C. VP, Gupta RR, Vyas K, H A, Mishra B. Exploring Alternatives to Softmax Function. arXiv, 2020. https:\/\/doi.org\/10.48550\/arXiv.2011.11538.","DOI":"10.48550\/arXiv.2011.11538"},{"key":"1107_CR43","doi-asserted-by":"publisher","unstructured":"Agarap AF. Deep learning using Rectified Linear Units (ReLU). arXiv, 2020. https:\/\/doi.org\/10.48550\/arXiv.1803.08375.","DOI":"10.48550\/arXiv.1803.08375"},{"key":"1107_CR44","doi-asserted-by":"publisher","unstructured":"Gulcehre C, Denil M, Malinowski M, et al. Hyperbolic attention networks. arXiv 2018. https:\/\/doi.org\/10.48550\/arXiv.1805.09786.","DOI":"10.48550\/arXiv.1805.09786"},{"key":"1107_CR45","unstructured":"Lydia AA, Francis FS. An optimizer for stochastic gradient descent. IJICS 2019;6;566-568."},{"key":"1107_CR46","doi-asserted-by":"publisher","unstructured":"Duda J. SGD momentum optimizer with step estimation by online parabola model. arXiv 2019. https:\/\/doi.org\/10.48550\/arXiv.1907.07063.","DOI":"10.48550\/arXiv.1907.07063"},{"key":"1107_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13195-021-00879-4","volume":"13","author":"L Bloch","year":"2021","unstructured":"Bloch L, Friedrich CM, et al. Data analysis with Shapley values for automatic subject selection in Alzheimer\u2019s disease data sets using interpretable machine learning. Alzheimers Res Ther. 2021;13:155.","journal-title":"Alzheimers Res Ther."},{"key":"1107_CR48","doi-asserted-by":"publisher","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. arXiv. 2017. https:\/\/doi.org\/10.48550\/arXiv.1705.07874.","DOI":"10.48550\/arXiv.1705.07874"},{"key":"1107_CR49","doi-asserted-by":"crossref","unstructured":"Akiba, Takuya, et al. Optuna: A next-generation hyperparameter optimization framework.\u00a0Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining 2019; pp. 2623\u201331.","DOI":"10.1145\/3292500.3330701"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-023-01107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-023-01107-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-023-01107-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:03:03Z","timestamp":1682776983000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-023-01107-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1186\/s12938-023-01107-w","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has ethical approval, consent to participate, and consent for publication. The institutional review board of all participating centers approved the study procedures (), The study was approved by the Kangwon National University Hospital institutional review boards (KNUH-2022-06-011) of all participating institutions, and written informed consent was obtained from all participants or their authorized representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}